ALONX Stock Price, News & Analysis

ALONX

Company Description

ALONX (OTC: ALONX) is a publicly traded company.

This page provides a comprehensive overview of ALONX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

January 13, 2022

—

Onxeo Announces its Financial Agenda for 2022

January 7, 2022

—

Summary of Onxeo’s Liquidity Contract With Kepler Cheuvreux

January 3, 2022

—

Onxeo Appoints Julien Miara as New Interim CEO

management

December 8, 2021

—

Onxeo: New Preclinical Data Confirm the Ability of AsiDNA™ to Tackle the Drug-Tolerant Persister Cells and Prevent Tumor Resistance in Several Combination Treatments

clinical trial

November 23, 2021

—

Onxeo Continues to Strengthen its Board of Directors

management

October 14, 2021

—

Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector

management

ALONX has 6 recent news articles. Key topics include management, clinical trial. View all ALONX news →

SEC Filings

View All

No SEC filings available for ALONX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months